Acorah Software Products - Accounts Production 19.4.300 false true 31 January 2025 1 December 2023 false 1 February 2025 31 January 2026 31 January 2026 03755987 S Daya S N Daya L R Lewis G Sinclair N L Sinclair G Sinclair iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 03755987 2025-01-31 03755987 2026-01-31 03755987 2025-02-01 2026-01-31 03755987 frs-core:CurrentFinancialInstruments 2026-01-31 03755987 frs-core:BetweenOneFiveYears 2026-01-31 03755987 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-02-01 2026-01-31 03755987 frs-core:FurnitureFittings 2026-01-31 03755987 frs-core:FurnitureFittings 2025-02-01 2026-01-31 03755987 frs-core:FurnitureFittings 2025-01-31 03755987 frs-core:OtherResidualIntangibleAssets 2026-01-31 03755987 frs-core:OtherResidualIntangibleAssets 2025-02-01 2026-01-31 03755987 frs-core:OtherResidualIntangibleAssets 2025-01-31 03755987 frs-core:WithinOneYear 2026-01-31 03755987 frs-core:ShareCapital 2026-01-31 03755987 frs-core:RetainedEarningsAccumulatedLosses 2026-01-31 03755987 frs-bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 03755987 frs-bus:FilletedAccounts 2025-02-01 2026-01-31 03755987 frs-bus:SmallEntities 2025-02-01 2026-01-31 03755987 frs-bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 03755987 frs-bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 03755987 frs-bus:OrdinaryShareClass2 2025-02-01 2026-01-31 03755987 frs-bus:OrdinaryShareClass2 2026-01-31 03755987 frs-bus:OrdinaryShareClass3 2025-02-01 2026-01-31 03755987 frs-bus:OrdinaryShareClass3 2026-01-31 03755987 frs-bus:OrdinaryShareClass4 2025-02-01 2026-01-31 03755987 frs-bus:OrdinaryShareClass4 2026-01-31 03755987 frs-core:DeferredTaxation 2025-02-01 2026-01-31 03755987 frs-core:DeferredTaxation 2025-01-31 03755987 frs-core:DeferredTaxation 2026-01-31 03755987 frs-bus:Director1 2025-02-01 2026-01-31 03755987 frs-bus:Director1 2025-01-31 03755987 frs-bus:Director1 2026-01-31 03755987 frs-bus:Director2 2025-02-01 2026-01-31 03755987 frs-bus:Director3 2025-02-01 2026-01-31 03755987 frs-bus:Director4 2025-02-01 2026-01-31 03755987 frs-bus:Director4 2025-01-31 03755987 frs-bus:Director4 2026-01-31 03755987 frs-bus:Director5 2025-02-01 2026-01-31 03755987 frs-bus:CompanySecretary1 2025-02-01 2026-01-31 03755987 frs-countries:EnglandWales 2025-02-01 2026-01-31 03755987 2023-11-30 03755987 2025-01-31 03755987 2023-12-01 2025-01-31 03755987 frs-core:CurrentFinancialInstruments 2025-01-31 03755987 frs-core:BetweenOneFiveYears 2025-01-31 03755987 frs-core:WithinOneYear 2025-01-31 03755987 frs-core:ShareCapital 2025-01-31 03755987 frs-core:RetainedEarningsAccumulatedLosses 2025-01-31 03755987 frs-bus:OrdinaryShareClass2 2023-12-01 2025-01-31 03755987 frs-bus:OrdinaryShareClass3 2023-12-01 2025-01-31 03755987 frs-bus:OrdinaryShareClass4 2023-12-01 2025-01-31
Registered number: 03755987
Victoriahealth.com Limited
Unaudited Financial Statements
For The Year Ended 31 January 2026
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—7
Page 1
Balance Sheet
Registered number: 03755987
31 January 2026 31 January 2025
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 - 76,268
Tangible Assets 5 11,364 13,898
11,364 90,166
CURRENT ASSETS
Stocks 6 1,192,469 1,233,060
Debtors 7 905,998 896,047
Cash at bank and in hand 652,075 417,348
2,750,542 2,546,455
Creditors: Amounts Falling Due Within One Year 8 (974,728 ) (934,953 )
NET CURRENT ASSETS (LIABILITIES) 1,775,814 1,611,502
TOTAL ASSETS LESS CURRENT LIABILITIES 1,787,178 1,701,668
PROVISIONS FOR LIABILITIES
Deferred Taxation (2,841 ) (22,542 )
NET ASSETS 1,784,337 1,679,126
CAPITAL AND RESERVES
Called up share capital 10 200 200
Profit and Loss Account 1,784,137 1,678,926
SHAREHOLDERS' FUNDS 1,784,337 1,679,126
Page 1
Page 2
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
S N Daya
Director
24 August 2026
The notes on pages 3 to 7 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Victoriahealth.com Limited is a private company, limited by shares, incorporated in England & Wales, registered number 03755987 . The registered office is Unit 5 Atlantic Business Centre, Stirling Way, Borehamwood, WD6 2FQ.
Reporting Period
The figures for the period ending 31 January 2025 were for an extended period, 14 months, and therefore are not entirely comparable to this year.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
The financial statements have been prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods and services, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances. 
2.3. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets comprise software. They are amortised to profit and loss account over their estimated economic life of four years. During the year, an impairment loss of £76,269 was recognised on software that is no longer in use. This loss is included in the profit and loss account.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 25% straight line
2.5. Stocks and Work in Progress
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. 
At each reporting date, an assessment is made for impairment. Any excess of the carrying amounts of stocks over the estimated seling price less costs to complete and sell is recognised as an impairment loss in the profit and loss account. Reversals of impairment losses are also recognosed in the profit and loss account.
Page 3
Page 4
2.6. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.7. Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 25 (2025: 23)
25 23
Page 4
Page 5
4. Intangible Assets
Other
£
Cost
As at 1 February 2025 433,571
As at 31 January 2026 433,571
Amortisation
As at 1 February 2025 357,303
Impairment losses 76,268
As at 31 January 2026 433,571
Net Book Value
As at 31 January 2026 -
As at 1 February 2025 76,268
5. Tangible Assets
Fixtures & Fittings
£
Cost
As at 1 February 2025 63,834
Additions 3,540
Disposals (12,491 )
As at 31 January 2026 54,883
Depreciation
As at 1 February 2025 49,936
Provided during the period 5,011
Disposals (11,428 )
As at 31 January 2026 43,519
Net Book Value
As at 31 January 2026 11,364
As at 1 February 2025 13,898
Page 5
Page 6
6. Stocks
31 January 2026 31 January 2025
£ £
Stock 1,192,469 1,233,060
7. Debtors
31 January 2026 31 January 2025
£ £
Due within one year
Trade debtors 106,576 66,180
Other debtors 799,422 829,867
905,998 896,047
8. Creditors: Amounts Falling Due Within One Year
31 January 2026 31 January 2025
£ £
Trade creditors 329,990 339,250
Corporation tax 238,063 218,261
Other taxes and social security 57,260 55,077
VAT 265,248 246,841
Other creditors 1,009 1,346
Accruals and deferred income 83,158 74,178
974,728 934,953
9. Provisions for Liabilities
Deferred Tax Total
£ £
As at 1 February 2025 22,542 22,542
Reversals (19,701 ) (19,701)
Balance at 31 January 2026 2,841 2,841
Page 6
Page 7
10. Share Capital
31 January 2026 31 January 2025
Allotted, called up and fully paid £ £
80 Ordinary A shares of £ 1.00 each 80 80
40 Ordinary B shares of £ 1.00 each 40 40
80 Ordinary C shares of £ 1.00 each 80 80
200 200
The Ordinary A, Ordinary B and Ordinary C shares have attached to them full voting, dividend and captial distribution rights (including on winding up). They do not confer any rights of redemption.
11. Other Commitments
The total of future minimum lease payments under non-cancellable operating leases are as following:
31 January 2026 31 January 2025
£ £
Not later than one year 134,370 106,471
Later than one year and not later than five years 211,201 247,000
345,571 353,471
12. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 February 2025 Amounts advanced Amounts repaid Amounts written off As at 31 January 2026
£ £ £ £ £
Mr Shabir Daya 394,920 135,634 152,926 - 367,628
Mrs Gillian Sinclair 79,267 2,731 - - 81,998
Interest was charged at 2.25% per annum up to March 2025 and at 3.75% per annum thereafter.
Page 7